Cardiovascular disease (CVD), a composite of coronary heart disease (CHD), cerebrovascular disease, and heart failure, ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

Researchers have flagged a chemical common in household products as an unexpected and serious cause of life-threatening liver ...

London's unhealthiest boroughs are today revealed by stark data that illustrates the capital's 'food deserts'.

Results of the Bayer-led Phase 3 FINE-ONE clinical trial, presented at the American Society of Nephrology Kidney Week in ...

What are called autoimmune diseases can affect just about every part of the body – and tens of millions of people. While most ...

The global Neurovascular Devices Market, valued at US$4.27 billion in 2024, stood at US$4.64 billion in 2025 and is projected ...

Older adults with T2D and chronic kidney disease who lack regular blood pressure monitoring in the 2 years before diagnosis ...

There is an “urgent need” for all GPs in England to be better trained to recognise signs of ADHD in a bid to help tackle long waits for care, according to a new report.

To raise awareness about the health impact of diabetes-related misconceptions, Abbott launched the Above the Bias initiative.

Eli Lilly and Company (NYSE: LLY) today announced positive results from a Phase 2 trial evaluating the safety and efficacy of ...